Status:
COMPLETED
Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2
Lead Sponsor:
Hospital Italiano de Buenos Aires
Conditions:
Postoperative Complications
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate Hemoglobin A1c values previous to a surgery in patients with diabetes type II and the complication incidence in immediate post surgery.
Detailed Description
The diabetes is a highly prevalent disease in patients who undergo an evaluation previous to a surgery. The most efficient glucose control, in patients with diabetes type II, reduces the risk of micro...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients older than 18 years with diagnosed of diabetes type 2
- Programmed major surgery with expected hospitalization longer than 24 hours
- Exclusion Criteria
- Refusal to participate in the study or the informed consent process.
- Programmed cardiac or coronary surgery
- Technical complications inherent to surgical or anatomical abnormalities.
- Pregnant women.
- Active infection prior to performing surgery
Exclusion
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
1760 Patients enrolled
Trial Details
Trial ID
NCT01403961
Start Date
July 1 2011
End Date
December 1 2017
Last Update
August 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina, C1181ACH